Gil-Alonso Sandra, Quindós Guillermo, Cantón Emilia, Eraso Elena, Jauregizar Nerea
Departamento de Inmunología, Microbiología y Parasitología, Unidad de formación e investigación multidisciplinar 'Microbios y Salud' (UFI 11/25), Facultad de Medicina y Enfermería, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Bilbao, Spain; Departamento de Farmacología, Unidad de formación e investigación multidisciplinar 'Microbios y Salud' (UFI 11/25), Facultad de Medicina y Enfermería, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Bilbao, Spain.
Departamento de Inmunología, Microbiología y Parasitología, Unidad de formación e investigación multidisciplinar 'Microbios y Salud' (UFI 11/25), Facultad de Medicina y Enfermería, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Bilbao, Spain.
Rev Iberoam Micol. 2019 Jan-Mar;36(1):24-29. doi: 10.1016/j.riam.2018.12.001. Epub 2019 Mar 2.
Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis are emerging as relevant causes of candidemia. Moreover, they show differences in their antifungal susceptibility and virulence. The echinocandins are different in terms of in vitro antifungal activity against Candida. Time-kill (TK) curves represent an excellent approach to evaluate the fungicidal activity of antifungal drugs.
To compare the fungicidal activities of anidulafungin, caspofungin and micafungin against C. parapsilosis species complex by TK curves.
Antifungal activities of three echinocandins against C. parapsilosis, C. metapsilosis and C. orthopsilosis were studied by TK curves. Drug concentrations assayed were 0.25, 2 and 8μg/ml. CFU/ml were determined at 0, 2, 4, 6, 24 and 48h.
Killing activities of echinocandins were species-, isolates- and concentration-dependent. Anidulafungin reached the fungicidad endpoint for 6 out of 7 isolates (86%); it required between 13.34 and 29.67h to reach this endpoint for the three species studied, but more than 48h were needed against one isolate of C. orthopsilosis (8μg/ml). Caspofungin fungicidal endpoint was only achieved with 8μg/ml against one isolate of C. metapsilosis after 30.12h (1 out of 7 isolates; 14%). Micafungin fungicidal endpoint was reached in 12.74-28.38h (8μg/ml) against one isolate each of C. parapsilosis and C. orthopsilosis, and against both C. metapsilosis isolates (4 out of 7 isolates; 57%).
C. metapsilosis was the most susceptible species to echinocandins, followed by C. orthopsilosis and C. parapsilosis. Anidulafungin was the most active echinocandin against C. parapsilosis complex.
近平滑念珠菌、间平滑念珠菌和正平滑念珠菌正逐渐成为念珠菌血症的相关病因。此外,它们在抗真菌药敏性和毒力方面存在差异。棘白菌素类药物对念珠菌的体外抗真菌活性各不相同。时间杀菌(TK)曲线是评估抗真菌药物杀菌活性的绝佳方法。
通过TK曲线比较阿尼芬净、卡泊芬净和米卡芬净对近平滑念珠菌复合菌种的杀菌活性。
采用TK曲线研究三种棘白菌素类药物对近平滑念珠菌、间平滑念珠菌和正平滑念珠菌的抗真菌活性。测定的药物浓度为0.25、2和8μg/ml。在0、2、4、6、24和48小时测定菌落形成单位/毫升(CFU/ml)。
棘白菌素类药物的杀菌活性具有菌种、菌株和浓度依赖性。阿尼芬净使7株分离菌中的6株(86%)达到杀菌终点;对于所研究的三种菌种,达到该终点需要13.34至29.67小时,但对于一株正平滑念珠菌分离菌(8μg/ml),则需要超过48小时。卡泊芬净仅在30.12小时后对一株间平滑念珠菌分离菌(8μg/ml)达到杀菌终点(7株分离菌中的1株;14%)。米卡芬净在12.74 - 28.38小时(8μg/ml)对一株近平滑念珠菌和一株正平滑念珠菌分离菌以及两株间平滑念珠菌分离菌均达到杀菌终点(7株分离菌中的4株;57%)。
间平滑念珠菌是对棘白菌素类药物最敏感的菌种,其次是正平滑念珠菌和平平滑念珠菌。阿尼芬净是针对近平滑念珠菌复合菌种最具活性的棘白菌素类药物。